K122514

Substantially Equivalent

VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST

Applicant: Nanosphere, Inc.
Product code: PAM
Advisory panel: Microbiology
Date received: 2012-08-17
Decision date: 2012-09-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Northbrook, IL, US

Adverse events under product code PAM

product code PAM

Death: 6
Malfunction: 598
Total: 604

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.